Evidence map›Paper›PMID 41476667›Full record

ArticleJugan geon-gang gwa jilbyeong2025

Status of Notifiable Infectious Diseases Reporting in the Republic of Korea: 2024 Surveillance Report.

Jin Ha, Shinjung Song, Jeongyun Park, Noori Park

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Jugan geon-gang gwa jilbyeong, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jin HaDivision of Infectious Disease Policy, Department of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea.ORCID https://orcid.org/0009-0003-4494-8792
Shinjung SongDivision of Infectious Disease Policy, Department of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea.ORCID https://orcid.org/0009-0005-5632-5351
Jeongyun ParkDivision of Infectious Disease Policy, Department of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea.ORCID https://orcid.org/0009-0009-5570-261X
Noori ParkDivision of Infectious Disease Policy, Department of Infectious Disease Policy, Korea Disease Control and Prevention Agency, Cheongju, Korea.ORCID https://orcid.org/0000-0002-2972-4366

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To analyze data collected through the National Infectious Disease Surveillance System to provide information on infectious disease outbreaks and deaths for use in infectious disease prevention and management. Methods: On June 26, 2025, the status of infectious disease outbreaks and deaths reported in 2024 was analyzed and announced, based on the reporting scope and criteria for each statutory infectious disease. Results: In 2024, 40 of 66 infectious diseases under surveillance were reported, whereas 26 remained unreported. The number of reported infectious diseases under surveillance is 171,376, a significant decrease from 5,626,627 in 2023. However, excluding coronavirus disease 2019 (COVID-19) and syphilis, which had fluctuations in infectious disease levels between 2023 and 2024, the number increased by 54.5% from 109,087 in 2023 to 168,586 in 2024. The major infectious diseases that showed an increase were pertussis, scarlet fever, chickenpox, and Carbapenem-resistant Conclusions: The statutory infectious disease surveillance system can be used to produce basic data and develop policies for infectious disease prevention and management.

Indexed as

Disease notificationKorea Disease Control and Prevention AgencyNational notifiable infectious diseasesPublic healthSurveillance

Identifiers

PMID41476667
PMCPMC12750143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.